nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—PRKCQ—type 1 diabetes mellitus	0.414	0.628	CbGaD
Bosutinib—ERBB3—type 1 diabetes mellitus	0.169	0.257	CbGaD
Bosutinib—EGFR—type 1 diabetes mellitus	0.076	0.115	CbGaD
Bosutinib—Cytolytic hepatitis—Ramipril—type 1 diabetes mellitus	0.00684	0.186	CcSEcCtD
Bosutinib—Lower respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0031	0.0843	CcSEcCtD
Bosutinib—Vandetanib—ERBB3—type 1 diabetes mellitus	0.00147	0.322	CrCbGaD
Bosutinib—Gefitinib—ERBB3—type 1 diabetes mellitus	0.0014	0.306	CrCbGaD
Bosutinib—ERBB3—peripheral nervous system—type 1 diabetes mellitus	0.00137	0.0136	CbGeAlD
Bosutinib—EPHB3—nerve—type 1 diabetes mellitus	0.00129	0.0128	CbGeAlD
Bosutinib—Liver injury—Ramipril—type 1 diabetes mellitus	0.00126	0.0342	CcSEcCtD
Bosutinib—WEE2—lymphoid tissue—type 1 diabetes mellitus	0.00118	0.0117	CbGeAlD
Bosutinib—CAMK2G—nerve—type 1 diabetes mellitus	0.00116	0.0116	CbGeAlD
Bosutinib—MAP3K3—peripheral nervous system—type 1 diabetes mellitus	0.00116	0.0115	CbGeAlD
Bosutinib—LRRK2—nerve—type 1 diabetes mellitus	0.00115	0.0114	CbGeAlD
Bosutinib—EPHA4—nerve—type 1 diabetes mellitus	0.00108	0.0107	CbGeAlD
Bosutinib—CLK3—islet of Langerhans—type 1 diabetes mellitus	0.000969	0.00963	CbGeAlD
Bosutinib—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.000962	0.0262	CcSEcCtD
Bosutinib—VRK2—islet of Langerhans—type 1 diabetes mellitus	0.000908	0.00902	CbGeAlD
Bosutinib—WEE1—islet of Langerhans—type 1 diabetes mellitus	0.000837	0.00832	CbGeAlD
Bosutinib—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.000832	0.0226	CcSEcCtD
Bosutinib—EPHB2—retina—type 1 diabetes mellitus	0.00081	0.00805	CbGeAlD
Bosutinib—Renal impairment—Ramipril—type 1 diabetes mellitus	0.000807	0.022	CcSEcCtD
Bosutinib—EIF2AK1—retina—type 1 diabetes mellitus	0.000801	0.00796	CbGeAlD
Bosutinib—PLK2—islet of Langerhans—type 1 diabetes mellitus	0.000777	0.00772	CbGeAlD
Bosutinib—VRK2—nephron tubule—type 1 diabetes mellitus	0.000731	0.00726	CbGeAlD
Bosutinib—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00072	0.0196	CcSEcCtD
Bosutinib—DMPK—retina—type 1 diabetes mellitus	0.000716	0.00711	CbGeAlD
Bosutinib—STK26—nephron tubule—type 1 diabetes mellitus	0.000704	0.00699	CbGeAlD
Bosutinib—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.000702	0.0191	CcSEcCtD
Bosutinib—BMX—cardiovascular system—type 1 diabetes mellitus	0.000701	0.00696	CbGeAlD
Bosutinib—PHKG1—cardiovascular system—type 1 diabetes mellitus	0.000685	0.00681	CbGeAlD
Bosutinib—CLK3—pancreas—type 1 diabetes mellitus	0.000681	0.00677	CbGeAlD
Bosutinib—Gastritis—Ramipril—type 1 diabetes mellitus	0.00068	0.0185	CcSEcCtD
Bosutinib—EPHA3—retina—type 1 diabetes mellitus	0.000679	0.00674	CbGeAlD
Bosutinib—WEE1—nephron tubule—type 1 diabetes mellitus	0.000674	0.0067	CbGeAlD
Bosutinib—Influenza—Ramipril—type 1 diabetes mellitus	0.000664	0.0181	CcSEcCtD
Bosutinib—Vandetanib—EGFR—type 1 diabetes mellitus	0.00066	0.145	CrCbGaD
Bosutinib—SRMS—kidney—type 1 diabetes mellitus	0.000656	0.00652	CbGeAlD
Bosutinib—STK25—nephron tubule—type 1 diabetes mellitus	0.000644	0.0064	CbGeAlD
Bosutinib—Bronchitis—Ramipril—type 1 diabetes mellitus	0.000638	0.0174	CcSEcCtD
Bosutinib—VRK2—pancreas—type 1 diabetes mellitus	0.000638	0.00634	CbGeAlD
Bosutinib—CDK2—cardiovascular system—type 1 diabetes mellitus	0.000638	0.00634	CbGeAlD
Bosutinib—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.000636	0.0173	CcSEcCtD
Bosutinib—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00063	0.0172	CcSEcCtD
Bosutinib—SYK—kidney—type 1 diabetes mellitus	0.00063	0.00626	CbGeAlD
Bosutinib—CAMK1D—retina—type 1 diabetes mellitus	0.000628	0.00624	CbGeAlD
Bosutinib—PRKCQ—lymphoid tissue—type 1 diabetes mellitus	0.000628	0.00624	CbGeAlD
Bosutinib—Gefitinib—EGFR—type 1 diabetes mellitus	0.000627	0.137	CrCbGaD
Bosutinib—CDK2—kidney—type 1 diabetes mellitus	0.000624	0.0062	CbGeAlD
Bosutinib—SIK3—nephron tubule—type 1 diabetes mellitus	0.000622	0.00618	CbGeAlD
Bosutinib—Neutropenia—Ramipril—type 1 diabetes mellitus	0.000621	0.0169	CcSEcCtD
Bosutinib—STK24—retina—type 1 diabetes mellitus	0.000621	0.00617	CbGeAlD
Bosutinib—STK26—kidney—type 1 diabetes mellitus	0.000619	0.00614	CbGeAlD
Bosutinib—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.000617	0.0168	CcSEcCtD
Bosutinib—STK26—pancreas—type 1 diabetes mellitus	0.000614	0.0061	CbGeAlD
Bosutinib—MAP4K4—islet of Langerhans—type 1 diabetes mellitus	0.000606	0.00602	CbGeAlD
Bosutinib—WEE1—cardiovascular system—type 1 diabetes mellitus	0.000606	0.00602	CbGeAlD
Bosutinib—DMPK—cardiovascular system—type 1 diabetes mellitus	0.000606	0.00602	CbGeAlD
Bosutinib—FRK—lymphoid tissue—type 1 diabetes mellitus	0.000603	0.00599	CbGeAlD
Bosutinib—BCR—islet of Langerhans—type 1 diabetes mellitus	0.000602	0.00598	CbGeAlD
Bosutinib—NUAK2—islet of Langerhans—type 1 diabetes mellitus	0.000602	0.00598	CbGeAlD
Bosutinib—EPHA5—retina—type 1 diabetes mellitus	0.000601	0.00597	CbGeAlD
Bosutinib—WEE1—pancreas—type 1 diabetes mellitus	0.000589	0.00585	CbGeAlD
Bosutinib—MAP4K1—retina—type 1 diabetes mellitus	0.000588	0.00585	CbGeAlD
Bosutinib—STK35—islet of Langerhans—type 1 diabetes mellitus	0.000585	0.00581	CbGeAlD
Bosutinib—BLK—lymphoid tissue—type 1 diabetes mellitus	0.000582	0.00578	CbGeAlD
Bosutinib—Renal failure—Ramipril—type 1 diabetes mellitus	0.000582	0.0158	CcSEcCtD
Bosutinib—CSK—islet of Langerhans—type 1 diabetes mellitus	0.000581	0.00578	CbGeAlD
Bosutinib—CSNK1A1—islet of Langerhans—type 1 diabetes mellitus	0.000578	0.00574	CbGeAlD
Bosutinib—EPHB2—lymphoid tissue—type 1 diabetes mellitus	0.000576	0.00572	CbGeAlD
Bosutinib—CLK1—islet of Langerhans—type 1 diabetes mellitus	0.000574	0.0057	CbGeAlD
Bosutinib—PLK2—cardiovascular system—type 1 diabetes mellitus	0.000562	0.00559	CbGeAlD
Bosutinib—STK25—pancreas—type 1 diabetes mellitus	0.000562	0.00558	CbGeAlD
Bosutinib—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00056	0.0152	CcSEcCtD
Bosutinib—TXK—lymphoid tissue—type 1 diabetes mellitus	0.000558	0.00554	CbGeAlD
Bosutinib—ROCK1—retina—type 1 diabetes mellitus	0.000554	0.0055	CbGeAlD
Bosutinib—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000552	0.015	CcSEcCtD
Bosutinib—PLK2—kidney—type 1 diabetes mellitus	0.00055	0.00546	CbGeAlD
Bosutinib—PLK2—pancreas—type 1 diabetes mellitus	0.000546	0.00543	CbGeAlD
Bosutinib—SYK—lymphoid tissue—type 1 diabetes mellitus	0.000541	0.00538	CbGeAlD
Bosutinib—CDK2—lymphoid tissue—type 1 diabetes mellitus	0.000536	0.00533	CbGeAlD
Bosutinib—CSNK1E—islet of Langerhans—type 1 diabetes mellitus	0.000535	0.00532	CbGeAlD
Bosutinib—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000531	0.0145	CcSEcCtD
Bosutinib—STK26—lymphoid tissue—type 1 diabetes mellitus	0.000531	0.00528	CbGeAlD
Bosutinib—MERTK—retina—type 1 diabetes mellitus	0.000528	0.00524	CbGeAlD
Bosutinib—SIK1—islet of Langerhans—type 1 diabetes mellitus	0.000527	0.00523	CbGeAlD
Bosutinib—IRAK4—islet of Langerhans—type 1 diabetes mellitus	0.000527	0.00523	CbGeAlD
Bosutinib—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000523	0.0142	CcSEcCtD
Bosutinib—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000522	0.0142	CcSEcCtD
Bosutinib—CAMK1D—pancreas—type 1 diabetes mellitus	0.000516	0.00513	CbGeAlD
Bosutinib—MAP2K2—islet of Langerhans—type 1 diabetes mellitus	0.000515	0.00512	CbGeAlD
Bosutinib—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000502	0.0137	CcSEcCtD
Bosutinib—PTK2—islet of Langerhans—type 1 diabetes mellitus	0.000501	0.00498	CbGeAlD
Bosutinib—TBK1—islet of Langerhans—type 1 diabetes mellitus	0.000501	0.00498	CbGeAlD
Bosutinib—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000495	0.0135	CcSEcCtD
Bosutinib—IRAK1—islet of Langerhans—type 1 diabetes mellitus	0.000491	0.00488	CbGeAlD
Bosutinib—CLK1—retina—type 1 diabetes mellitus	0.000491	0.00487	CbGeAlD
Bosutinib—MAP4K4—nephron tubule—type 1 diabetes mellitus	0.000488	0.00485	CbGeAlD
Bosutinib—STK25—lymphoid tissue—type 1 diabetes mellitus	0.000486	0.00483	CbGeAlD
Bosutinib—NUAK2—nephron tubule—type 1 diabetes mellitus	0.000484	0.00481	CbGeAlD
Bosutinib—BCR—nephron tubule—type 1 diabetes mellitus	0.000484	0.00481	CbGeAlD
Bosutinib—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00048	0.0131	CcSEcCtD
Bosutinib—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000479	0.013	CcSEcCtD
Bosutinib—ERBB4—cardiovascular system—type 1 diabetes mellitus	0.000475	0.00472	CbGeAlD
Bosutinib—PLK2—lymphoid tissue—type 1 diabetes mellitus	0.000472	0.00469	CbGeAlD
Bosutinib—ROCK1—cardiovascular system—type 1 diabetes mellitus	0.000469	0.00466	CbGeAlD
Bosutinib—CSK—nephron tubule—type 1 diabetes mellitus	0.000468	0.00465	CbGeAlD
Bosutinib—CSNK1A1—nephron tubule—type 1 diabetes mellitus	0.000465	0.00462	CbGeAlD
Bosutinib—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000463	0.0126	CcSEcCtD
Bosutinib—CLK1—nephron tubule—type 1 diabetes mellitus	0.000462	0.00459	CbGeAlD
Bosutinib—SLK—islet of Langerhans—type 1 diabetes mellitus	0.000459	0.00456	CbGeAlD
Bosutinib—ROCK1—kidney—type 1 diabetes mellitus	0.000459	0.00456	CbGeAlD
Bosutinib—CSNK1E—retina—type 1 diabetes mellitus	0.000458	0.00455	CbGeAlD
Bosutinib—EPHB4—islet of Langerhans—type 1 diabetes mellitus	0.000456	0.00453	CbGeAlD
Bosutinib—BMPR2—cardiovascular system—type 1 diabetes mellitus	0.000455	0.00452	CbGeAlD
Bosutinib—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000453	0.0123	CcSEcCtD
Bosutinib—STK4—lymphoid tissue—type 1 diabetes mellitus	0.000452	0.00449	CbGeAlD
Bosutinib—EPHA2—islet of Langerhans—type 1 diabetes mellitus	0.000447	0.00444	CbGeAlD
Bosutinib—BMPR2—kidney—type 1 diabetes mellitus	0.000445	0.00442	CbGeAlD
Bosutinib—ULK3—retina—type 1 diabetes mellitus	0.00044	0.00438	CbGeAlD
Bosutinib—MAP4K4—cardiovascular system—type 1 diabetes mellitus	0.000438	0.00435	CbGeAlD
Bosutinib—MAP4K5—islet of Langerhans—type 1 diabetes mellitus	0.000436	0.00433	CbGeAlD
Bosutinib—MAP3K7—retina—type 1 diabetes mellitus	0.000433	0.0043	CbGeAlD
Bosutinib—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000429	0.0117	CcSEcCtD
Bosutinib—MAP4K4—kidney—type 1 diabetes mellitus	0.000429	0.00426	CbGeAlD
Bosutinib—FER—lymphoid tissue—type 1 diabetes mellitus	0.000427	0.00424	CbGeAlD
Bosutinib—ALK—lymphoid tissue—type 1 diabetes mellitus	0.000427	0.00424	CbGeAlD
Bosutinib—TYRO3—lymphoid tissue—type 1 diabetes mellitus	0.000427	0.00424	CbGeAlD
Bosutinib—MAP4K4—pancreas—type 1 diabetes mellitus	0.000426	0.00423	CbGeAlD
Bosutinib—LYN—lymphoid tissue—type 1 diabetes mellitus	0.000425	0.00422	CbGeAlD
Bosutinib—SIK1—nephron tubule—type 1 diabetes mellitus	0.000424	0.00421	CbGeAlD
Bosutinib—MAP2K1—cardiovascular system—type 1 diabetes mellitus	0.000423	0.0042	CbGeAlD
Bosutinib—NUAK2—pancreas—type 1 diabetes mellitus	0.000423	0.0042	CbGeAlD
Bosutinib—CSK—cardiovascular system—type 1 diabetes mellitus	0.00042	0.00418	CbGeAlD
Bosutinib—MAP4K1—lymphoid tissue—type 1 diabetes mellitus	0.000418	0.00416	CbGeAlD
Bosutinib—CSNK1A1—cardiovascular system—type 1 diabetes mellitus	0.000418	0.00415	CbGeAlD
Bosutinib—Malaise—Ramipril—type 1 diabetes mellitus	0.000417	0.0114	CcSEcCtD
Bosutinib—BTK—lymphoid tissue—type 1 diabetes mellitus	0.000416	0.00413	CbGeAlD
Bosutinib—ERBB3—nephron tubule—type 1 diabetes mellitus	0.000416	0.00413	CbGeAlD
Bosutinib—CLK1—cardiovascular system—type 1 diabetes mellitus	0.000415	0.00412	CbGeAlD
Bosutinib—MAP2K1—kidney—type 1 diabetes mellitus	0.000414	0.00411	CbGeAlD
Bosutinib—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000414	0.0113	CcSEcCtD
Bosutinib—RPS6KB1—retina—type 1 diabetes mellitus	0.000412	0.00409	CbGeAlD
Bosutinib—MAP3K2—nephron tubule—type 1 diabetes mellitus	0.000412	0.00409	CbGeAlD
Bosutinib—CSK—kidney—type 1 diabetes mellitus	0.000411	0.00409	CbGeAlD
Bosutinib—STK35—pancreas—type 1 diabetes mellitus	0.000411	0.00409	CbGeAlD
Bosutinib—CSNK1A1—kidney—type 1 diabetes mellitus	0.000409	0.00406	CbGeAlD
Bosutinib—CSK—pancreas—type 1 diabetes mellitus	0.000409	0.00406	CbGeAlD
Bosutinib—AXL—retina—type 1 diabetes mellitus	0.000408	0.00405	CbGeAlD
Bosutinib—CAMK2G—cardiovascular system—type 1 diabetes mellitus	0.000407	0.00405	CbGeAlD
Bosutinib—CLK1—kidney—type 1 diabetes mellitus	0.000406	0.00403	CbGeAlD
Bosutinib—CSNK1A1—pancreas—type 1 diabetes mellitus	0.000406	0.00403	CbGeAlD
Bosutinib—MAP4K2—lymphoid tissue—type 1 diabetes mellitus	0.000404	0.00402	CbGeAlD
Bosutinib—Cough—Ramipril—type 1 diabetes mellitus	0.000404	0.011	CcSEcCtD
Bosutinib—CLK1—pancreas—type 1 diabetes mellitus	0.000403	0.00401	CbGeAlD
Bosutinib—TBK1—nephron tubule—type 1 diabetes mellitus	0.000403	0.00401	CbGeAlD
Bosutinib—PTK2—nephron tubule—type 1 diabetes mellitus	0.000403	0.00401	CbGeAlD
Bosutinib—YES1—islet of Langerhans—type 1 diabetes mellitus	0.000403	0.004	CbGeAlD
Bosutinib—TAOK3—islet of Langerhans—type 1 diabetes mellitus	0.000398	0.00395	CbGeAlD
Bosutinib—CAMK2G—pancreas—type 1 diabetes mellitus	0.000396	0.00393	CbGeAlD
Bosutinib—IRAK1—nephron tubule—type 1 diabetes mellitus	0.000395	0.00393	CbGeAlD
Bosutinib—LRRK2—kidney—type 1 diabetes mellitus	0.000395	0.00392	CbGeAlD
Bosutinib—ROCK1—lymphoid tissue—type 1 diabetes mellitus	0.000394	0.00391	CbGeAlD
Bosutinib—Chest pain—Ramipril—type 1 diabetes mellitus	0.000394	0.0107	CcSEcCtD
Bosutinib—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000394	0.0107	CcSEcCtD
Bosutinib—Myalgia—Ramipril—type 1 diabetes mellitus	0.000394	0.0107	CcSEcCtD
Bosutinib—PTK2B—cardiovascular system—type 1 diabetes mellitus	0.000393	0.00391	CbGeAlD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000391	0.0106	CcSEcCtD
Bosutinib—Discomfort—Ramipril—type 1 diabetes mellitus	0.000389	0.0106	CcSEcCtD
Bosutinib—SRC—islet of Langerhans—type 1 diabetes mellitus	0.000388	0.00385	CbGeAlD
Bosutinib—PTK2B—kidney—type 1 diabetes mellitus	0.000385	0.00382	CbGeAlD
Bosutinib—BMPR2—lymphoid tissue—type 1 diabetes mellitus	0.000383	0.0038	CbGeAlD
Bosutinib—Oedema—Ramipril—type 1 diabetes mellitus	0.000378	0.0103	CcSEcCtD
Bosutinib—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000378	0.0103	CcSEcCtD
Bosutinib—CSNK1E—pancreas—type 1 diabetes mellitus	0.000376	0.00374	CbGeAlD
Bosutinib—MERTK—lymphoid tissue—type 1 diabetes mellitus	0.000375	0.00373	CbGeAlD
Bosutinib—SIK1—kidney—type 1 diabetes mellitus	0.000373	0.0037	CbGeAlD
Bosutinib—MAP2K2—cardiovascular system—type 1 diabetes mellitus	0.000373	0.0037	CbGeAlD
Bosutinib—SIK1—pancreas—type 1 diabetes mellitus	0.00037	0.00368	CbGeAlD
Bosutinib—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00037	0.0101	CcSEcCtD
Bosutinib—SLK—nephron tubule—type 1 diabetes mellitus	0.00037	0.00367	CbGeAlD
Bosutinib—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00037	0.0101	CcSEcCtD
Bosutinib—MAP4K4—lymphoid tissue—type 1 diabetes mellitus	0.000368	0.00366	CbGeAlD
Bosutinib—EPHB4—nephron tubule—type 1 diabetes mellitus	0.000367	0.00365	CbGeAlD
Bosutinib—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000367	0.00998	CcSEcCtD
Bosutinib—BCR—lymphoid tissue—type 1 diabetes mellitus	0.000366	0.00363	CbGeAlD
Bosutinib—ERBB3—kidney—type 1 diabetes mellitus	0.000365	0.00363	CbGeAlD
Bosutinib—MAP2K2—kidney—type 1 diabetes mellitus	0.000365	0.00362	CbGeAlD
Bosutinib—ERBB3—pancreas—type 1 diabetes mellitus	0.000363	0.00361	CbGeAlD
Bosutinib—TBK1—cardiovascular system—type 1 diabetes mellitus	0.000362	0.0036	CbGeAlD
Bosutinib—PTK2—cardiovascular system—type 1 diabetes mellitus	0.000362	0.0036	CbGeAlD
Bosutinib—MAP2K2—pancreas—type 1 diabetes mellitus	0.000362	0.0036	CbGeAlD
Bosutinib—EPHA2—nephron tubule—type 1 diabetes mellitus	0.00036	0.00358	CbGeAlD
Bosutinib—FYN—nephron tubule—type 1 diabetes mellitus	0.000359	0.00357	CbGeAlD
Bosutinib—MAP2K1—lymphoid tissue—type 1 diabetes mellitus	0.000356	0.00353	CbGeAlD
Bosutinib—PTK2—kidney—type 1 diabetes mellitus	0.000354	0.00352	CbGeAlD
Bosutinib—TBK1—kidney—type 1 diabetes mellitus	0.000354	0.00352	CbGeAlD
Bosutinib—CSK—lymphoid tissue—type 1 diabetes mellitus	0.000353	0.00351	CbGeAlD
Bosutinib—TBK1—pancreas—type 1 diabetes mellitus	0.000352	0.0035	CbGeAlD
Bosutinib—PTK2—pancreas—type 1 diabetes mellitus	0.000352	0.0035	CbGeAlD
Bosutinib—MAP3K3—nephron tubule—type 1 diabetes mellitus	0.000351	0.00349	CbGeAlD
Bosutinib—CSNK1A1—lymphoid tissue—type 1 diabetes mellitus	0.000351	0.00349	CbGeAlD
Bosutinib—HCK—lymphoid tissue—type 1 diabetes mellitus	0.000349	0.00346	CbGeAlD
Bosutinib—CLK1—lymphoid tissue—type 1 diabetes mellitus	0.000349	0.00346	CbGeAlD
Bosutinib—RPS6KB1—cardiovascular system—type 1 diabetes mellitus	0.000349	0.00346	CbGeAlD
Bosutinib—FGR—cardiovascular system—type 1 diabetes mellitus	0.000346	0.00344	CbGeAlD
Bosutinib—IRAK1—pancreas—type 1 diabetes mellitus	0.000345	0.00343	CbGeAlD
Bosutinib—AXL—cardiovascular system—type 1 diabetes mellitus	0.000345	0.00343	CbGeAlD
Bosutinib—YES1—retina—type 1 diabetes mellitus	0.000345	0.00342	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000344	0.00936	CcSEcCtD
Bosutinib—RPS6KB1—kidney—type 1 diabetes mellitus	0.000341	0.00339	CbGeAlD
Bosutinib—TAOK3—retina—type 1 diabetes mellitus	0.00034	0.00338	CbGeAlD
Bosutinib—RPS6KB1—pancreas—type 1 diabetes mellitus	0.000339	0.00337	CbGeAlD
Bosutinib—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000337	0.00916	CcSEcCtD
Bosutinib—SRC—retina—type 1 diabetes mellitus	0.000331	0.00329	CbGeAlD
Bosutinib—PTK2B—lymphoid tissue—type 1 diabetes mellitus	0.000331	0.00328	CbGeAlD
Bosutinib—EPHB4—cardiovascular system—type 1 diabetes mellitus	0.00033	0.00328	CbGeAlD
Bosutinib—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000328	0.00893	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000326	0.00887	CcSEcCtD
Bosutinib—Fatigue—Ramipril—type 1 diabetes mellitus	0.000325	0.00886	CcSEcCtD
Bosutinib—YES1—nephron tubule—type 1 diabetes mellitus	0.000324	0.00322	CbGeAlD
Bosutinib—EPHA2—cardiovascular system—type 1 diabetes mellitus	0.000323	0.00321	CbGeAlD
Bosutinib—FYN—cardiovascular system—type 1 diabetes mellitus	0.000323	0.00321	CbGeAlD
Bosutinib—SLK—pancreas—type 1 diabetes mellitus	0.000323	0.00321	CbGeAlD
Bosutinib—EPHB4—kidney—type 1 diabetes mellitus	0.000323	0.0032	CbGeAlD
Bosutinib—EPHB4—pancreas—type 1 diabetes mellitus	0.00032	0.00318	CbGeAlD
Bosutinib—TAOK3—nephron tubule—type 1 diabetes mellitus	0.00032	0.00318	CbGeAlD
Bosutinib—SIK1—lymphoid tissue—type 1 diabetes mellitus	0.00032	0.00318	CbGeAlD
Bosutinib—IRAK4—lymphoid tissue—type 1 diabetes mellitus	0.00032	0.00318	CbGeAlD
Bosutinib—FYN—kidney—type 1 diabetes mellitus	0.000316	0.00314	CbGeAlD
Bosutinib—MAP3K3—cardiovascular system—type 1 diabetes mellitus	0.000316	0.00313	CbGeAlD
Bosutinib—EPHA2—pancreas—type 1 diabetes mellitus	0.000314	0.00312	CbGeAlD
Bosutinib—ERBB3—lymphoid tissue—type 1 diabetes mellitus	0.000314	0.00312	CbGeAlD
Bosutinib—MAP2K2—lymphoid tissue—type 1 diabetes mellitus	0.000313	0.00311	CbGeAlD
Bosutinib—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000311	0.00847	CcSEcCtD
Bosutinib—MAP3K2—lymphoid tissue—type 1 diabetes mellitus	0.000311	0.00309	CbGeAlD
Bosutinib—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000309	0.0084	CcSEcCtD
Bosutinib—PDGFRB—islet of Langerhans—type 1 diabetes mellitus	0.000309	0.00307	CbGeAlD
Bosutinib—MAP4K5—pancreas—type 1 diabetes mellitus	0.000307	0.00305	CbGeAlD
Bosutinib—PTK2—lymphoid tissue—type 1 diabetes mellitus	0.000304	0.00302	CbGeAlD
Bosutinib—TBK1—lymphoid tissue—type 1 diabetes mellitus	0.000304	0.00302	CbGeAlD
Bosutinib—Urticaria—Ramipril—type 1 diabetes mellitus	0.0003	0.00816	CcSEcCtD
Bosutinib—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000298	0.00812	CcSEcCtD
Bosutinib—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000298	0.00812	CcSEcCtD
Bosutinib—RPS6KB1—lymphoid tissue—type 1 diabetes mellitus	0.000293	0.00291	CbGeAlD
Bosutinib—FGR—lymphoid tissue—type 1 diabetes mellitus	0.000291	0.00289	CbGeAlD
Bosutinib—AXL—lymphoid tissue—type 1 diabetes mellitus	0.00029	0.00288	CbGeAlD
Bosutinib—STK10—cardiovascular system—type 1 diabetes mellitus	0.000289	0.00287	CbGeAlD
Bosutinib—TAOK3—cardiovascular system—type 1 diabetes mellitus	0.000288	0.00286	CbGeAlD
Bosutinib—YES1—kidney—type 1 diabetes mellitus	0.000285	0.00283	CbGeAlD
Bosutinib—YES1—pancreas—type 1 diabetes mellitus	0.000283	0.00281	CbGeAlD
Bosutinib—STK10—kidney—type 1 diabetes mellitus	0.000283	0.00281	CbGeAlD
Bosutinib—TAOK3—kidney—type 1 diabetes mellitus	0.000281	0.0028	CbGeAlD
Bosutinib—SRC—cardiovascular system—type 1 diabetes mellitus	0.00028	0.00279	CbGeAlD
Bosutinib—TAOK3—pancreas—type 1 diabetes mellitus	0.00028	0.00278	CbGeAlD
Bosutinib—ABL1—islet of Langerhans—type 1 diabetes mellitus	0.000275	0.00273	CbGeAlD
Bosutinib—SRC—kidney—type 1 diabetes mellitus	0.000274	0.00272	CbGeAlD
Bosutinib—SRC—pancreas—type 1 diabetes mellitus	0.000272	0.00271	CbGeAlD
Bosutinib—EPHA2—lymphoid tissue—type 1 diabetes mellitus	0.000272	0.0027	CbGeAlD
Bosutinib—FYN—lymphoid tissue—type 1 diabetes mellitus	0.000271	0.0027	CbGeAlD
Bosutinib—Asthenia—Ramipril—type 1 diabetes mellitus	0.000271	0.00737	CcSEcCtD
Bosutinib—Pruritus—Ramipril—type 1 diabetes mellitus	0.000267	0.00727	CcSEcCtD
Bosutinib—MAP4K5—lymphoid tissue—type 1 diabetes mellitus	0.000265	0.00263	CbGeAlD
Bosutinib—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000258	0.00703	CcSEcCtD
Bosutinib—MAP2K5—cardiovascular system—type 1 diabetes mellitus	0.000258	0.00256	CbGeAlD
Bosutinib—CSF1R—cardiovascular system—type 1 diabetes mellitus	0.000252	0.0025	CbGeAlD
Bosutinib—Dizziness—Ramipril—type 1 diabetes mellitus	0.00025	0.0068	CcSEcCtD
Bosutinib—YES1—lymphoid tissue—type 1 diabetes mellitus	0.000245	0.00243	CbGeAlD
Bosutinib—STK10—lymphoid tissue—type 1 diabetes mellitus	0.000243	0.00241	CbGeAlD
Bosutinib—TAOK3—lymphoid tissue—type 1 diabetes mellitus	0.000242	0.0024	CbGeAlD
Bosutinib—Vomiting—Ramipril—type 1 diabetes mellitus	0.00024	0.00653	CcSEcCtD
Bosutinib—Rash—Ramipril—type 1 diabetes mellitus	0.000238	0.00648	CcSEcCtD
Bosutinib—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000238	0.00647	CcSEcCtD
Bosutinib—Headache—Ramipril—type 1 diabetes mellitus	0.000237	0.00644	CcSEcCtD
Bosutinib—SRC—lymphoid tissue—type 1 diabetes mellitus	0.000236	0.00234	CbGeAlD
Bosutinib—ABL1—retina—type 1 diabetes mellitus	0.000235	0.00234	CbGeAlD
Bosutinib—Nausea—Ramipril—type 1 diabetes mellitus	0.000224	0.0061	CcSEcCtD
Bosutinib—PDGFRB—cardiovascular system—type 1 diabetes mellitus	0.000223	0.00222	CbGeAlD
Bosutinib—ABL1—nephron tubule—type 1 diabetes mellitus	0.000221	0.0022	CbGeAlD
Bosutinib—PDGFRB—kidney—type 1 diabetes mellitus	0.000218	0.00217	CbGeAlD
Bosutinib—PDGFRB—pancreas—type 1 diabetes mellitus	0.000217	0.00216	CbGeAlD
Bosutinib—CSF1R—lymphoid tissue—type 1 diabetes mellitus	0.000212	0.0021	CbGeAlD
Bosutinib—Vandetanib—ALB—type 1 diabetes mellitus	0.00021	0.0461	CrCbGaD
Bosutinib—Gefitinib—ALB—type 1 diabetes mellitus	0.0002	0.0438	CrCbGaD
Bosutinib—ABL1—cardiovascular system—type 1 diabetes mellitus	0.000199	0.00198	CbGeAlD
Bosutinib—ABL1—kidney—type 1 diabetes mellitus	0.000195	0.00193	CbGeAlD
Bosutinib—ABL1—pancreas—type 1 diabetes mellitus	0.000193	0.00192	CbGeAlD
Bosutinib—PDGFRB—lymphoid tissue—type 1 diabetes mellitus	0.000188	0.00186	CbGeAlD
Bosutinib—ABL1—lymphoid tissue—type 1 diabetes mellitus	0.000167	0.00166	CbGeAlD
Bosutinib—ABCB1—islet of Langerhans—type 1 diabetes mellitus	8.55e-05	0.00085	CbGeAlD
Bosutinib—CYP3A4—kidney—type 1 diabetes mellitus	8.55e-05	0.000849	CbGeAlD
Bosutinib—ABCB1—retina—type 1 diabetes mellitus	7.31e-05	0.000727	CbGeAlD
Bosutinib—ABCB1—nephron tubule—type 1 diabetes mellitus	6.89e-05	0.000684	CbGeAlD
Bosutinib—ABCB1—cardiovascular system—type 1 diabetes mellitus	6.19e-05	0.000615	CbGeAlD
Bosutinib—ABCB1—kidney—type 1 diabetes mellitus	6.05e-05	0.000601	CbGeAlD
Bosutinib—ABCB1—pancreas—type 1 diabetes mellitus	6.01e-05	0.000597	CbGeAlD
Bosutinib—ABCB1—lymphoid tissue—type 1 diabetes mellitus	5.2e-05	0.000516	CbGeAlD
Bosutinib—MAP2K1—Disease—CD4—type 1 diabetes mellitus	1.42e-06	7.15e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.42e-06	7.14e-06	CbGpPWpGaD
Bosutinib—BLK—Immune System—IL6—type 1 diabetes mellitus	1.42e-06	7.13e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL2—type 1 diabetes mellitus	1.42e-06	7.13e-06	CbGpPWpGaD
Bosutinib—FGR—Immune System—IL6—type 1 diabetes mellitus	1.41e-06	7.11e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—EGFR—type 1 diabetes mellitus	1.41e-06	7.08e-06	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—IL6—type 1 diabetes mellitus	1.41e-06	7.07e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.4e-06	7.06e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.4e-06	7.04e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.39e-06	7.01e-06	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—IL6—type 1 diabetes mellitus	1.39e-06	6.99e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IFNG—type 1 diabetes mellitus	1.38e-06	6.96e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CD80—type 1 diabetes mellitus	1.38e-06	6.94e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—EGFR—type 1 diabetes mellitus	1.38e-06	6.93e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.38e-06	6.93e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.37e-06	6.92e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TYK2—type 1 diabetes mellitus	1.36e-06	6.87e-06	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—IL6—type 1 diabetes mellitus	1.36e-06	6.86e-06	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.36e-06	6.86e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.36e-06	6.86e-06	CbGpPWpGaD
Bosutinib—ERBB4—Disease—IL6—type 1 diabetes mellitus	1.36e-06	6.84e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CD80—type 1 diabetes mellitus	1.36e-06	6.84e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.36e-06	6.83e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.35e-06	6.79e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.35e-06	6.77e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.35e-06	6.77e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.34e-06	6.76e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—NOS3—type 1 diabetes mellitus	1.34e-06	6.74e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD4—type 1 diabetes mellitus	1.34e-06	6.73e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IFNG—type 1 diabetes mellitus	1.33e-06	6.71e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CD80—type 1 diabetes mellitus	1.33e-06	6.7e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.33e-06	6.67e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—EGFR—type 1 diabetes mellitus	1.32e-06	6.67e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CD86—type 1 diabetes mellitus	1.32e-06	6.66e-06	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—EGFR—type 1 diabetes mellitus	1.32e-06	6.66e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.32e-06	6.65e-06	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—IL6—type 1 diabetes mellitus	1.32e-06	6.63e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—INS—type 1 diabetes mellitus	1.32e-06	6.62e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TYK2—type 1 diabetes mellitus	1.31e-06	6.62e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CD80—type 1 diabetes mellitus	1.31e-06	6.59e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.31e-06	6.58e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.3e-06	6.56e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—INS—type 1 diabetes mellitus	1.3e-06	6.56e-06	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL6—type 1 diabetes mellitus	1.3e-06	6.53e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.29e-06	6.51e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—NOS3—type 1 diabetes mellitus	1.29e-06	6.5e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD4—type 1 diabetes mellitus	1.29e-06	6.48e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—INS—type 1 diabetes mellitus	1.28e-06	6.46e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—STAT3—type 1 diabetes mellitus	1.27e-06	6.41e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.27e-06	6.41e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.27e-06	6.41e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL2—type 1 diabetes mellitus	1.27e-06	6.4e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.27e-06	6.37e-06	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.26e-06	6.36e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—TYK2—type 1 diabetes mellitus	1.26e-06	6.35e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—INS—type 1 diabetes mellitus	1.26e-06	6.33e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.26e-06	6.32e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.26e-06	6.32e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.25e-06	6.31e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.25e-06	6.27e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.25e-06	6.27e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—STAT3—type 1 diabetes mellitus	1.24e-06	6.25e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.24e-06	6.25e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—type 1 diabetes mellitus	1.24e-06	6.25e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.24e-06	6.24e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—INS—type 1 diabetes mellitus	1.24e-06	6.23e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—type 1 diabetes mellitus	1.23e-06	6.21e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—type 1 diabetes mellitus	1.23e-06	6.21e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—INS—type 1 diabetes mellitus	1.23e-06	6.2e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL2—type 1 diabetes mellitus	1.23e-06	6.19e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.22e-06	6.15e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—STAT3—type 1 diabetes mellitus	1.22e-06	6.12e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.22e-06	6.12e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—STAT3—type 1 diabetes mellitus	1.21e-06	6.09e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.2e-06	6.05e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—type 1 diabetes mellitus	1.2e-06	6.03e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—type 1 diabetes mellitus	1.2e-06	6.03e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—STAT3—type 1 diabetes mellitus	1.2e-06	6.03e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.2e-06	6.03e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—type 1 diabetes mellitus	1.2e-06	6.02e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.19e-06	6.01e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—STAT3—type 1 diabetes mellitus	1.19e-06	6e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.19e-06	5.99e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.19e-06	5.99e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—type 1 diabetes mellitus	1.19e-06	5.99e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—type 1 diabetes mellitus	1.19e-06	5.98e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.19e-06	5.98e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.19e-06	5.96e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL2—type 1 diabetes mellitus	1.19e-06	5.96e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFNG—type 1 diabetes mellitus	1.18e-06	5.94e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.18e-06	5.92e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.18e-06	5.92e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—STAT3—type 1 diabetes mellitus	1.18e-06	5.92e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.17e-06	5.91e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TYK2—type 1 diabetes mellitus	1.16e-06	5.86e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—EGFR—type 1 diabetes mellitus	1.16e-06	5.82e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.16e-06	5.82e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—type 1 diabetes mellitus	1.16e-06	5.82e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.15e-06	5.81e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.15e-06	5.78e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.15e-06	5.77e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—STAT3—type 1 diabetes mellitus	1.15e-06	5.77e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.15e-06	5.77e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS3—type 1 diabetes mellitus	1.14e-06	5.75e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—type 1 diabetes mellitus	1.14e-06	5.74e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—type 1 diabetes mellitus	1.14e-06	5.74e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.13e-06	5.7e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.13e-06	5.7e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CD80—type 1 diabetes mellitus	1.13e-06	5.7e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—EGFR—type 1 diabetes mellitus	1.13e-06	5.68e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.13e-06	5.67e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.12e-06	5.65e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.12e-06	5.64e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2—type 1 diabetes mellitus	1.12e-06	5.63e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.11e-06	5.57e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—STAT3—type 1 diabetes mellitus	1.11e-06	5.57e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—EGFR—type 1 diabetes mellitus	1.11e-06	5.57e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.1e-06	5.55e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—type 1 diabetes mellitus	1.1e-06	5.54e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—EGFR—type 1 diabetes mellitus	1.1e-06	5.54e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.1e-06	5.54e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—STAT3—type 1 diabetes mellitus	1.1e-06	5.54e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.09e-06	5.5e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CD80—type 1 diabetes mellitus	1.09e-06	5.49e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—EGFR—type 1 diabetes mellitus	1.09e-06	5.48e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.09e-06	5.46e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—EGFR—type 1 diabetes mellitus	1.08e-06	5.45e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—type 1 diabetes mellitus	1.08e-06	5.44e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.08e-06	5.43e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.07e-06	5.38e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—INS—type 1 diabetes mellitus	1.07e-06	5.38e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—EGFR—type 1 diabetes mellitus	1.07e-06	5.38e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—type 1 diabetes mellitus	1.06e-06	5.33e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.05e-06	5.31e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—type 1 diabetes mellitus	1.05e-06	5.3e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—type 1 diabetes mellitus	1.05e-06	5.3e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2—type 1 diabetes mellitus	1.05e-06	5.28e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—EGFR—type 1 diabetes mellitus	1.04e-06	5.25e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—STAT3—type 1 diabetes mellitus	1.03e-06	5.21e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.03e-06	5.21e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—INS—type 1 diabetes mellitus	1.03e-06	5.19e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—type 1 diabetes mellitus	1.02e-06	5.12e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—EGFR—type 1 diabetes mellitus	1.01e-06	5.06e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1e-06	5.04e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—EGFR—type 1 diabetes mellitus	1e-06	5.03e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—STAT3—type 1 diabetes mellitus	9.97e-07	5.02e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.97e-07	5.02e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.8e-07	4.93e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2—type 1 diabetes mellitus	9.78e-07	4.92e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.73e-07	4.9e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	9.73e-07	4.89e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.72e-07	4.89e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	9.67e-07	4.87e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CD80—type 1 diabetes mellitus	9.66e-07	4.86e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.59e-07	4.83e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.56e-07	4.81e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.55e-07	4.81e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—STAT3—type 1 diabetes mellitus	9.55e-07	4.81e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2—type 1 diabetes mellitus	9.55e-07	4.81e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—type 1 diabetes mellitus	9.52e-07	4.79e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.42e-07	4.74e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—type 1 diabetes mellitus	9.38e-07	4.72e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.38e-07	4.72e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.36e-07	4.71e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2—type 1 diabetes mellitus	9.35e-07	4.7e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.22e-07	4.64e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.21e-07	4.63e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—STAT3—type 1 diabetes mellitus	9.21e-07	4.63e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2—type 1 diabetes mellitus	9.2e-07	4.63e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.17e-07	4.61e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2—type 1 diabetes mellitus	9.15e-07	4.61e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—INS—type 1 diabetes mellitus	9.12e-07	4.59e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.11e-07	4.58e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	9.1e-07	4.58e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.09e-07	4.58e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—EGFR—type 1 diabetes mellitus	9.06e-07	4.56e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	9.05e-07	4.55e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—type 1 diabetes mellitus	9.04e-07	4.55e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.04e-07	4.55e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—type 1 diabetes mellitus	8.89e-07	4.48e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	8.88e-07	4.47e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—STAT3—type 1 diabetes mellitus	8.83e-07	4.44e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.82e-07	4.44e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—type 1 diabetes mellitus	8.71e-07	4.38e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—type 1 diabetes mellitus	8.71e-07	4.38e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—type 1 diabetes mellitus	8.68e-07	4.37e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.56e-07	4.31e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—type 1 diabetes mellitus	8.5e-07	4.28e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—type 1 diabetes mellitus	8.46e-07	4.26e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—type 1 diabetes mellitus	8.39e-07	4.22e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—EGFR—type 1 diabetes mellitus	8.37e-07	4.21e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—type 1 diabetes mellitus	8.37e-07	4.21e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—type 1 diabetes mellitus	8.32e-07	4.19e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.23e-07	4.14e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—type 1 diabetes mellitus	8.21e-07	4.13e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.15e-07	4.1e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—STAT3—type 1 diabetes mellitus	8.15e-07	4.1e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.03e-07	4.04e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—EGFR—type 1 diabetes mellitus	8.02e-07	4.04e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—type 1 diabetes mellitus	8.01e-07	4.03e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOS3—type 1 diabetes mellitus	8e-07	4.03e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.96e-07	4.01e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2—type 1 diabetes mellitus	7.95e-07	4e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.91e-07	3.98e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.87e-07	3.96e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.74e-07	3.9e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—type 1 diabetes mellitus	7.72e-07	3.89e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.7e-07	3.88e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—type 1 diabetes mellitus	7.68e-07	3.87e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.67e-07	3.86e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2—type 1 diabetes mellitus	7.66e-07	3.86e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.48e-07	3.77e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—type 1 diabetes mellitus	7.47e-07	3.76e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—EGFR—type 1 diabetes mellitus	7.41e-07	3.73e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—type 1 diabetes mellitus	7.37e-07	3.71e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.3e-07	3.68e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—type 1 diabetes mellitus	7.23e-07	3.64e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.15e-07	3.6e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	7.08e-07	3.56e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.04e-07	3.54e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EGFR—type 1 diabetes mellitus	7e-07	3.52e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—type 1 diabetes mellitus	6.99e-07	3.52e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—type 1 diabetes mellitus	6.97e-07	3.51e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.79e-07	3.42e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2—type 1 diabetes mellitus	6.78e-07	3.41e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.69e-07	3.37e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—type 1 diabetes mellitus	6.67e-07	3.36e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—type 1 diabetes mellitus	6.58e-07	3.31e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—INS—type 1 diabetes mellitus	6.46e-07	3.25e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.45e-07	3.24e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—type 1 diabetes mellitus	6.43e-07	3.24e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—type 1 diabetes mellitus	6.17e-07	3.1e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	5.99e-07	3.02e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	5.92e-07	2.98e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.86e-07	2.95e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—type 1 diabetes mellitus	5.75e-07	2.89e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.71e-07	2.87e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—type 1 diabetes mellitus	5.69e-07	2.87e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	5.66e-07	2.85e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—type 1 diabetes mellitus	5.61e-07	2.82e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—type 1 diabetes mellitus	5.49e-07	2.77e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—type 1 diabetes mellitus	5.41e-07	2.72e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.38e-07	2.71e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.19e-07	2.61e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—type 1 diabetes mellitus	4.67e-07	2.35e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—type 1 diabetes mellitus	4.5e-07	2.27e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—type 1 diabetes mellitus	3.99e-07	2.01e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.98e-07	2e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	3.65e-07	1.84e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	3.49e-07	1.76e-06	CbGpPWpGaD
